Teede H - Search Results

1

Development of a risk prediction model for postpartum onset of type 2 diabetes mellitus, following gestational diabetes; the lifestyle InterVention in gestational diabetes (LIVING) study.

Belsti Y, Moran LJ, Goldstein R, Mousa A, Cooray SD, Baker S, Gupta Y, Patel A, Tandon N, Ajanthan S, John R, Naheed A, Chakma N, Lakshmi JK, Zoungas S, Billot L, Desai A, Bhatla N, Prabhakaran D, Gupta I, de Silva HA, Kapoor D, Praveen D, Farzana N, Enticott J, Teede H. Belsti Y, et al. Among authors: teede h. Clin Nutr. 2024 Aug;43(8):1728-1735. doi: 10.1016/j.clnu.2024.06.006. Epub 2024 Jun 8. Clin Nutr. 2024. PMID: 38909514 Free article.

2

Placebo-controlled trial of transdermal estrogen therapy alone in postmenopausal women: effects on arterial compliance and endothelial function.

Teede HJ, Liang YL, Kotsopoulos D, Zoungas S, Craven R, McGrath BP. Teede HJ, et al. Climacteric. 2002 Jun;5(2):160-9. Climacteric. 2002. PMID: 12051112 Clinical Trial.

3

Insulin resistance, the metabolic syndrome, diabetes, and cardiovascular disease risk in women with PCOS.

Teede HJ, Hutchison S, Zoungas S, Meyer C. Teede HJ, et al. Endocrine. 2006 Aug;30(1):45-53. doi: 10.1385/ENDO:30:1:45. Endocrine. 2006. PMID: 17185791 Review.

4

The management of insulin resistance in polycystic ovary syndrome.

Teede HJ, Hutchison SK, Zoungas S. Teede HJ, et al. Trends Endocrinol Metab. 2007 Sep;18(7):273-9. doi: 10.1016/j.tem.2007.08.001. Epub 2007 Aug 16. Trends Endocrinol Metab. 2007. PMID: 17698366 Review.

5

Risk perception in women: a focus on menopause.

Deeks A, Zoungas S, Teede H. Deeks A, et al. Among authors: teede h. Menopause. 2008 Mar-Apr;15(2):304-9. doi: 10.1097/gme.0b013e31812f7b65. Menopause. 2008. PMID: 18090036

6

The impact of glycaemic control on outcomes in patients with end-stage renal disease and type 2 diabetes.

Zoungas S, Kerr PG, Lui M, Teede HJ. Zoungas S, et al. Nephrology (Carlton). 2008 Apr;13(2):124-7. doi: 10.1111/j.1440-1797.2007.00901.x. Nephrology (Carlton). 2008. PMID: 18275500 Review.

7

A comprehensive assessment of endothelial function in overweight women with and without polycystic ovary syndrome.

Moran LJ, Hutchison SK, Meyer C, Zoungas S, Teede HJ. Moran LJ, et al. Clin Sci (Lond). 2009 May;116(10):761-70. doi: 10.1042/CS20080218. Clin Sci (Lond). 2009. PMID: 18851710

8

Endothelial function and insulin resistance in polycystic ovary syndrome: the effects of medical therapy.

Teede HJ, Meyer C, Hutchison SK, Zoungas S, McGrath BP, Moran LJ. Teede HJ, et al. Fertil Steril. 2010 Jan;93(1):184-91. doi: 10.1016/j.fertnstert.2008.09.034. Epub 2008 Nov 18. Fertil Steril. 2010. PMID: 19019358 Free article. Clinical Trial.

9

Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society.

Moran LJ, Pasquali R, Teede HJ, Hoeger KM, Norman RJ. Moran LJ, et al. Fertil Steril. 2009 Dec;92(6):1966-82. doi: 10.1016/j.fertnstert.2008.09.018. Epub 2008 Dec 4. Fertil Steril. 2009. PMID: 19062007 Free article.

10

Metabolic features of the reproductive phenotypes of polycystic ovary syndrome.

Moran L, Teede H. Moran L, et al. Among authors: teede h. Hum Reprod Update. 2009 Jul-Aug;15(4):477-88. doi: 10.1093/humupd/dmp008. Epub 2009 Mar 11. Hum Reprod Update. 2009. PMID: 19279045 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

636 results

Search Page

Filters